8/9/24 16:30 | 8/7/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | S.m | -61 | 0.1899 | 0 | -322 | -5 | 6,318 | D | | | | | | | | | | | | | | |
8/7/24 16:30 | 8/5/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | S.m | -41 | 0.1870 | 0 | -220 | -3 | 6,640 | D | | | | | | | | | | | | | | |
8/5/24 16:53 | 8/1/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | S.m | -71 | 0.2033 | 0 | -350 | -5 | 6,860 | D | | | | | | | | | | | | | | |
7/30/24 17:16 | 7/26/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | S.m | -315 | 0.2286 | 0 | -1,379 | -16 | 7,210 | D | | | | | | | | | | | | | | |
6/24/24 16:29 | 6/20/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | P.m | 79 | 0.2584 | 0 | 305 | 81 | 680 | D | | | | | | | | | | | | | | |
6/20/24 16:15 | 6/18/24 | GLYC | Health | Drug | Pharmaceutical Preparations | Hahn Brian M. | MD | O | SVP Fina | P | 4 | 0.2477 | 0 | 18 | 33 | 71 | D | | | | | | | | | | | | | | |
9/25/23 16:21 | 9/21/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | P.m | 90 | 1.38 | 0 | 65 | 21 | 375 | D | | | | | | | | | | | | | | |
6/2/23 16:10 | 6/1/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Koenig Scott | MD | D | | M.d | 13 | 0.6000 | 0 | 21 | 133 | 37 | D | | | | | | | | | | | | | | |
5/18/23 16:27 | 5/17/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Hahn Brian M. | MD | O | SVP Fina | S | -7 | 1.95 | 0 | -4 | -7 | 53 | D | | | | | | | | | | | | | | |
5/11/23 17:08 | 5/10/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Junius Daniel M | MD | D | | P | 47 | 1.56 | 0 | 30 | 47 | 93 | D | | | | | | | | | | | | | | |
5/9/23 17:00 | 5/8/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Johnson Bruce S | MD | O | SVP,Chie | P | 21 | 1.57 | 0 | 14 | 11 | 139 | D | | | | | | | | | | | | | | |
2/23/23 18:23 | 2/21/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | P.m | 712 | 1.78 | 0 | 400 | 5 | 8,489 | D | | | | | | | | | | | | | | |
2/17/23 17:29 | 2/15/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | P.m | 3,028 | 2.00 | 0 | 1,515 | 23 | 8,089 | D | | | | | | | | | | | | | | |
2/13/23 17:45 | 2/9/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Invus Public Equities, L.P. | NY | T | | P | 37 | 3.24 | 0 | 11 | 0 | 6,574 | D | | | | | | | | | | | | | | |
1/30/23 16:13 | 1/27/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Koenig Scott | MD | D | | M.d | 27 | 2.55 | 0 | 11 | 200 | 16 | D | | | | | | | | | | | | | | |
1/27/23 17:15 | 1/25/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Sandell Scott D | MD | T | | S.m | -11,485 | 3.14 | 0 | -3,652 | -42 | 4,968 | I | | | | | | | | | | | | | | |
1/6/23 18:35 | 1/5/23 | GLYC | Health | Drug | Pharmaceutical Preparations | Sandell Scott D | MD | T | | S | -197 | 2.76 | 0 | -71 | -1 | 8,620 | I | | | | | | | | | | | | | | |
1/4/23 17:26 | 12/30/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Sandell Scott D | MD | T | | S.m | -1,186 | 2.98 | 0 | -398 | -4 | 8,691 | I | | | | | | | | | | | | | | |
12/27/22 18:41 | 12/22/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | P | 248 | 2.25 | 0 | 110 | 55 | 310 | D | | | | | | | | | | | | | | |
11/18/22 16:01 | 11/17/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Junius Daniel M | MD | D | | P | 37 | 1.87 | 0 | 20 | 46 | 63 | D | | | | | | | | | | | | | | |
11/16/22 16:26 | 11/14/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Rock Edwin | MD | O | Chief Me | P.m | 309 | 1.55 | 0 | 200 | New | 200 | D | | | | | | | | | | | | | | |
11/14/22 16:14 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Pearson Timothy R | MD | D | | P | 25 | 1.29 | 0 | 19 | 370 | 25 | D | | | | | | | | | | | | | | |
11/14/22 16:13 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Semerjian Harout | MD | DO | CEO | P | 32 | 1.29 | 0 | 25 | New | 25 | D | | | | | | | | | | | | | | |
11/14/22 16:13 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Hahn Brian M. | MD | O | SVP Fina | P | 21 | 1.06 | 0 | 20 | 54 | 57 | D | | | | | | | | | | | | | | |
11/14/22 16:11 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Magnani John L. | MD | O | SVP of R | P | 53 | 1.17 | 0 | 45 | 14 | 371 | D | | | | | | | | | | | | | | |
11/14/22 16:04 | 11/11/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Girard Armand | MD | O | SVP,Chie | P | 7 | 1.05 | 0 | 7 | 29 | 29 | D | | | | | | | | | | | | | | |
3/10/22 17:06 | 3/9/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Magnani John L. | MD | O | SVP of R | S | -4 | 1.09 | 0 | -3 | -1 | 326 | D | | | | | | | | | | | | | | |
3/10/22 17:05 | 3/9/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Girard Armand | MD | O | SVP,Chie | S | -3 | 1.09 | 0 | -2 | -9 | 23 | D | | | | | | | | | | | | | | |
3/10/22 17:03 | 3/9/22 | GLYC | Health | Drug | Pharmaceutical Preparations | Hahn Brian M. | MD | O | SVP Fina | S | -3 | 1.09 | 0 | -3 | -7 | 37 | D | | | | | | | | | | | | | | |
11/18/21 16:05 | 11/16/21 | GLYC | Health | Drug | Pharmaceutical Preparations | Andrews Patricia S | MD | D | | P | 82 | 2.05 | 0 | 40 | 762 | 45 | D | | | | | | | | | | | | | | |
12/30/20 16:00 | 12/28/20 | GLYC | Health | Drug | Pharmaceutical Preparations | King Rachel K. | MD | DO | P,CEO | M.d | 147 | 1.12 | 0 | 131 | 33 | 531 | D | | | | | | | | | | | | | | |
12/30/20 16:00 | 12/28/20 | GLYC | Health | Drug | Pharmaceutical Preparations | King Rachel K. | MD | DO | P,CEO | S.d | -329 | 3.91 | 0 | -84 | -14 | 531 | D | | | | | | | | | | | | | | |
12/17/20 16:00 | 12/16/20 | GLYC | Health | Drug | Pharmaceutical Preparations | Hahn Brian M. | MD | O | SVP Fina | M.d | 6 | 1.12 | 0 | 5 | New | 5 | D | | | | | | | | | | | | | | |
11/6/20 18:33 | 11/4/20 | GLYC | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | | P | 3,294 | 2.60 | 0 | 1,267 | | 630 | D | | | | | | | | | | | | | | |
11/3/20 16:44 | 10/30/20 | GLYC | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | | P | 2,565 | 2.75 | 0 | 933 | | 544 | D | | | | | | | | | | | | | | |
3/10/20 18:12 | 3/9/20 | GLYC | Health | Drug | Pharmaceutical Preparations | Junius Daniel M | MD | D | | P | 68 | 3.40 | 0 | 20 | 111 | 38 | D | | | | | | | | | | | | | | |
1/6/20 18:23 | 1/6/20 | GLYC | Health | Drug | Pharmaceutical Preparations | Magnani John L. | MD | O | SVP of R | M.d | 120 | 1.12 | 0 | 107 | 57 | 295 | D | | | | | | | | | | | | | | |
12/23/19 16:13 | 12/20/19 | GLYC | Health | Drug | Pharmaceutical Preparations | Magnani John L. | MD | O | SVP of R | M.d | 120 | 1.12 | 0 | 107 | 133 | 188 | D | | | | | | | | | | | | | | |
9/9/19 16:49 | 9/5/19 | GLYC | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | | P | 5,310 | 3.18 | 0 | 1,669 | | 529 | D | | | | | | | | | | | | | | |
8/15/19 16:03 | 8/13/19 | GLYC | Health | Drug | Pharmaceutical Preparations | Junius Daniel M | MD | D | | P | 32 | 3.18 | 0 | 10 | 125 | 18 | D | | | | | | | | | | | | | | |
8/7/19 16:29 | 8/6/19 | GLYC | Health | Drug | Pharmaceutical Preparations | King Rachel K. | MD | DO | P,CEO | M.d | 187 | 1.12 | 0 | 167 | 52 | 485 | D | | | | | | | | | | | | | | |
10/18/18 17:36 | 10/16/18 | GLYC | Health | Drug | Pharmaceutical Preparations | Magnani John L. | MD | DO | SVP of R | S.m | -350 | 14.01 | 0 | -25 | -24 | 81 | D | | | | | | | | | | | | | | |
6/12/18 17:54 | 6/11/18 | GLYC | Health | Drug | Pharmaceutical Preparations | Hahn Brian M. | MD | O | CFO | M.d | 6 | 1.12 | 0 | 5 | | 0 | D | | | | | | | | | | | | | | |
6/12/18 17:54 | 6/11/18 | GLYC | Health | Drug | Pharmaceutical Preparations | Hahn Brian M. | MD | O | CFO | S.d | -349 | 18.04 | 0 | -19 | -100 | 0 | D | | | | | | | | | | | | | | |
5/24/18 17:11 | 5/23/18 | GLYC | Health | Drug | Pharmaceutical Preparations | Magnani John L. | MD | DO | SVP of R | M.d | 0 | 0.3300 | 0 | 1 | 1 | 106 | D | | | | | | | | | | | | | | |
5/11/18 17:02 | 5/10/18 | GLYC | Health | Drug | Pharmaceutical Preparations | Sandell Scott D | MD | T | | S.d | -170 | 17.81 | 0 | -10 | 0 | 9,089 | I | | | | | | | | | | | | | | |
5/11/18 17:01 | 5/10/18 | GLYC | Health | Drug | Pharmaceutical Preparations | Barris Peter J | MD | T | | S.d | -170 | 17.81 | 0 | -10 | 0 | 9,089 | I | | | | | | | | | | | | | | |
5/11/18 17:00 | 5/10/18 | GLYC | Health | Drug | Pharmaceutical Preparations | Barrett M James | MD | DT | | S.d | -170 | 17.81 | 0 | -10 | 0 | 9,089 | I | | | | | | | | | | | | | | |
5/11/18 17:00 | 5/10/18 | GLYC | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 10 L P | MD | T | | S.d | -170 | 17.81 | 0 | -10 | 0 | 4,996 | D | | | | | | | | | | | | | | |
12/12/17 16:14 | 12/8/17 | GLYC | Health | Drug | Pharmaceutical Preparations | Thackray Helen M. | MD | O | SVP Clin | S | -30 | 15.01 | 0 | -2 | -1 | 149 | D | | | | | | | | | | | | | | |
9/18/17 18:15 | 9/18/17 | GLYC | Health | Drug | Pharmaceutical Preparations | Thackray Helen M. | MD | O | SVP Clin | S | -26 | 13.00 | 0 | -2 | -1 | 151 | D | | | | | | | | | | | | | | |
5/30/17 16:07 | 5/25/17 | GLYC | Health | Drug | Pharmaceutical Preparations | Thackray Helen M. | MD | O | SVP Clin | S | -31 | 15.57 | 0 | -2 | -1 | 153 | D | | | | | | | | | | | | | | |
5/22/17 21:23 | 5/19/17 | GLYC | Health | Drug | Pharmaceutical Preparations | Thackray Helen M. | MD | O | SVP Clin | S | -24 | 12.14 | 0 | -2 | -1 | 155 | D | | | | | | | | | | | | | | |
5/11/17 16:00 | 5/10/17 | GLYC | Health | Drug | Pharmaceutical Preparations | Magnani John L. | MD | DO | SVP of R | M.d | 10 | 1.12 | 0 | 9 | 9 | 104 | D | -53 | -38 | -35 | -36 | -31 | -16 | -9 | 0 | 23 | | | | | |
12/21/16 16:23 | 12/20/16 | GLYC | Health | Drug | Pharmaceutical Preparations | Junius Daniel M | MD | D | | P | 30 | 6.01 | 0 | 5 | New | 5 | D | -30 | -4 | -2 | -18 | 4 | -4 | 3 | 0 | 1 | 1 | -5 | -6 | | |
10/4/16 16:22 | 10/3/16 | GLYC | Health | Drug | Pharmaceutical Preparations | Thackray Helen M. | MD | O | VP Clini | S | -28 | 7.00 | 0 | -4 | -2 | 157 | D | -7 | 20 | 11 | -1 | -14 | 0 | -7 | -5 | -1 | -5 | -8 | -5 | -24 | |
7/21/16 17:27 | 7/20/16 | GLYC | Health | Drug | Pharmaceutical Preparations | Thackray Helen M. | MD | O | VP Clini | S | -16 | 8.00 | 1 | -2 | -1 | 161 | D | -1 | 8 | 68 | 30 | -3 | 13 | 9 | 3 | 0 | 5 | -1 | -23 | -28 | |
7/6/16 17:07 | 7/1/16 | GLYC | Health | Drug | Pharmaceutical Preparations | Thackray Helen M. | MD | O | VP Clini | S.m | -154 | 7.00 | 1 | -22 | -12 | 163 | D | -26 | -7 | 17 | 12 | -13 | -5 | -3 | -4 | 2 | 12 | 27 | 1 | -6 | |
7/1/16 11:43 | 6/29/16 | GLYC | Health | Drug | Pharmaceutical Preparations | Baldwin John J. | MD | D | | M.d | 1 | 1.12 | 1 | 1 | 100 | 1 | D | -21 | -3 | 23 | 15 | 3 | -14 | 15 | 11 | 3 | -2 | 22 | -8 | -17 | |
3/7/16 08:03 | 3/4/16 | GLYC | Health | Drug | Pharmaceutical Preparations | Goldberg Mark Alan | MD | D | | P | 50 | 4.77 | 0 | 10 | 945 | 11 | D | -65 | -37 | -26 | -25 | 3 | 32 | 4 | 15 | 18 | 9 | 18 | 73 | 43 | 24 |
2/12/16 15:30 | 2/5/16 | GLYC | Health | Drug | Pharmaceutical Preparations | Top Franklin H Jr | MD | D | | M.d | 13 | 1.12 | 0 | 12 | 999% | 12 | D | -61 | -50 | -50 | -44 | -36 | -25 | -17 | -7 | 3 | 37 | 50 | 62 | 108 | 68 |
11/18/15 14:20 | 11/16/15 | GLYC | Health | Drug | Pharmaceutical Preparations | Sandell Scott D | MD | T | | S.d | -3 | 6.91 | 0 | 0 | 0 | 8,584 | I | | -6 | -21 | -4 | 4 | 1 | 0 | 1 | -4 | -2 | -8 | -25 | 2 | -7 |
11/18/15 14:20 | 11/16/15 | GLYC | Health | Drug | Pharmaceutical Preparations | Barris Peter J | MD | T | | S.d | -3 | 6.91 | 0 | 0 | 0 | 8,584 | I | | -6 | -21 | -4 | 4 | 1 | 0 | 1 | -4 | -2 | -8 | -25 | 2 | -7 |
11/18/15 14:19 | 11/16/15 | GLYC | Health | Drug | Pharmaceutical Preparations | Barrett M James | MD | DT | | S.d | -3 | 6.91 | 0 | 0 | 0 | 8,584 | I | | -6 | -21 | -4 | 4 | 1 | 0 | 1 | -4 | -2 | -8 | -25 | 2 | -7 |
11/18/15 14:18 | 11/16/15 | GLYC | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 10 L P | MD | T | | S.d | -3 | 6.91 | 0 | 0 | 0 | 4,491 | D | | -6 | -21 | -4 | 4 | 1 | 0 | 1 | -4 | -2 | -8 | -25 | 2 | -7 |
3/3/15 16:08 | 2/27/15 | GLYC | Health | Drug | Pharmaceutical Preparations | Hahn Brian M. | MD | O | CFO | M.d | 6 | 1.12 | 0 | 5 | 55 | 14 | D | | -30 | 6 | -9 | 21 | 16 | 5 | 4 | -1 | -2 | -1 | -7 | -16 | -46 |
2/26/15 17:02 | 2/24/15 | GLYC | Health | Drug | Pharmaceutical Preparations | King Rachel K. | MD | DO | P,CEO | M.d | 56 | 1.12 | 0 | 50 | 19 | 318 | D | | -36 | 4 | -11 | 16 | 13 | 5 | 1 | 1 | 1 | -3 | 0 | -15 | -43 |
12/23/14 16:30 | 12/19/14 | GLYC | Health | Drug | Pharmaceutical Preparations | Henos Michael A | MD | D | | S.m | -181 | 8.52 | 0 | -21 | -4 | 505 | I | | | 22 | -2 | 2 | -9 | -4 | -10 | -5 | -12 | -17 | -3 | 0 | -22 |
12/17/14 18:10 | 12/15/14 | GLYC | Health | Drug | Pharmaceutical Preparations | Henos Michael A | MD | D | | S.dm | -60 | 8.97 | 0 | -7 | -1 | 526 | I | | | 26 | 13 | 16 | -6 | -3 | 1 | 0 | -10 | -23 | -6 | -15 | -31 |
6/20/14 16:00 | 6/18/14 | GLYC | Health | Drug | Pharmaceutical Preparations | King Rachel K. | MD | DO | P,CEO | M.d | 112 | 1.12 | 1 | 100 | 60 | 268 | D | | | | -49 | -26 | 1 | 9 | 11 | -10 | -7 | 5 | -5 | 17 | -1 |
6/13/14 16:01 | 6/12/14 | GLYC | Health | Drug | Pharmaceutical Preparations | Henos Michael A | MD | D | | P.m | 70 | 6.39 | 1 | 11 | 2 | 489 | D | | | | -61 | -49 | -1 | -11 | -5 | 7 | 18 | 45 | 26 | 41 | 26 |
4/3/14 16:38 | 4/3/14 | GLYC | Health | Drug | Pharmaceutical Preparations | Henos Michael A | MD | D | | M.d | 2 | 1.12 | 4 | 2 | 0 | 478 | D | | | | | 61 | -2 | 13 | 9 | -1 | -3 | -24 | -40 | -52 | -47 |
1/15/14 17:16 | 1/15/14 | GLYC | Health | Drug | Pharmaceutical Preparations | Barris Peter J | MD | T | | P.d | 8,000 | 8.00 | 13 | 1,000 | 13 | 8,575 | I | | | | | | | | | 18 | 6 | 9 | 46 | -15 | -29 |
1/15/14 17:15 | 1/15/14 | GLYC | Health | Drug | Pharmaceutical Preparations | Sandell Scott D | MD | T | | P.d | 8,000 | 8.00 | 13 | 1,000 | 13 | 8,575 | I | | | | | | | | | 18 | 6 | 9 | 46 | -15 | -29 |
1/15/14 17:15 | 1/15/14 | GLYC | Health | Drug | Pharmaceutical Preparations | Barrett M James | MD | DT | | P.d | 8,000 | 8.00 | 13 | 1,000 | 13 | 8,575 | I | | | | | | | | | 18 | 6 | 9 | 46 | -15 | -29 |
1/15/14 17:14 | 1/15/14 | GLYC | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 13 LP | MD | T | | P.d | 4,100 | 8.00 | 13 | 513 | 14 | 4,093 | D | | | | | | | | | 18 | 6 | 9 | 46 | -15 | -29 |
1/15/14 17:13 | 1/15/14 | GLYC | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 10 L P | MD | T | | P.d | 3,900 | 8.00 | 13 | 488 | 12 | 4,482 | D | | | | | | | | | 18 | 6 | 9 | 46 | -15 | -29 |